Kappa Bioscience AS Revenue and Competitors

Claim your profile

OSLO, Norway

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kappa Bioscience AS's estimated annual revenue is currently $11.8M per year.(i)
  • Kappa Bioscience AS's estimated revenue per employee is $155,000

Employee Data

  • Kappa Bioscience AS has 76 Employees.(i)
  • Kappa Bioscience AS grew their employee count by 27% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.5M8730%N/AN/A
#2
$2.6M17-45%N/AN/A
#3
$2.6M176%N/AN/A
#4
$9.1M599%N/AN/A
#5
$3.7M249%N/AN/A
#6
$6.8M4416%N/AN/A
#7
$11.8M7627%N/AN/A

Kappa Bioscience is the pioneer in development and production of the only synthetic and biologically active all-trans menaquinone-7 (vitamin K2 MK-7), marketed under the K2VITAL® brand name. Kappa's innovation of MK-7 synthesis marks the commercial milestone where this fat-soluble vitamin can begin to attain widespread consumer adoption. Effective synthesis production drives scalability, price reduction and a secure supply chain - with unmatched ingredient purity and documentation. Combined with other Kappa innovations such as the patented DELTA® microencapsulation process, which provides K2 stability in mineral formulations, K2VITAL® offers brands and manufacturers a path to broader market segments. Kappa Ingredients GmbH, a wholly owned division of Kappa Bioscience, manages global sales of the K2VITAL® and other product lines directly and through a network of global distributors. Kappa Ingredients GmbH, a wholly owned division of Kappa Bioscience, manages global sales of the K2VITAL® and other product lines - Ingredients and services related to Bones, Joints and Cardiovascular Health - directly and through a network of global distributors. Main products are Vitamin K2 - K2VITAL®, Calcified Atlantic Seaweed®, The Bone Health Triangle®.

keywords:N/A

N/A

Total Funding

76

Number of Employees

$11.8M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kappa Bioscience AS News

2022-04-17 - Vitamin K2 Market is Going to Boom | Kappa Bioscience ...

Kappa Bioscience [Norway] , NattoPharma [Norway], Gnosis [Italy], DSM [Netherlands] , Viridis BioPharma [India] , Frutarom [Israel] , DuPont...

2022-04-17 - Global Vitamin K2 Market 2022 Product Scope – Kappa ...

The study provides a detailed profile of key players which include: Kappa Bioscience; NattoPharma; Gnosis; Guandong Sungen; Viridis BioPharma...

2022-04-17 - Kappa Bioscience appoints Rena Cohen-First as vice ...

Kappa Bioscience (Oslo, Norway) appointed Rena Cohen-First as vice president of sales North America. Previously, Cohen-First was vice...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M7767%N/A
#2
$25.2M7810%N/A
#3
$16.8M8043%N/A
#4
$20M8045%N/A
#5
$14.6M815%N/A